QGAI
Quantum Genesis AI Corp.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- TrendDOWNTREND
62% below its 50-day average.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
SecBot reports
4 filings · 0 bullish · 0 bearish · 4 neutral- NEUTRAL 10-Q/AApr 15, 2026
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's…
This is a procedural disclosure update with no financial implications. Traders should note that the company continues to operate with substantial doubt about its going concern status, but this…
- NEUTRAL 10-Q/AApr 15, 2026
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual…
No trading implication from this filing; it is a procedural disclosure update. However, traders should note the prior late filing and ongoing going concern uncertainty as potential red flags for…
- NEUTRAL 10-K/AApr 15, 2026
Quantum Genesis AI Corp. (formerly Quantumzyme Corp.) filed an amended 10-K/A to clarify…
Traders should monitor for future disclosures on the valuation of this intellectual property, which could impact the balance sheet. The prior late filing and current IP clarification suggest…
- NEUTRAL 8-KApr 15, 2026
Quantum Genesis AI Corp. filed a confirmatory Intellectual Property Assignment Agreement to…
Traders should note this is a procedural filing to document existing IP ownership, not a new strategic development. The core value of the patent (for enzymatic ibuprofen synthesis) remains…
All QGAI filing & press-release reports (4)
- 10-Q/A reportApr 15, 2026
- 10-Q/A reportApr 15, 2026
- 10-K/A reportApr 15, 2026
- 8-K reportApr 15, 2026